Skip to main content
Fig. 1 | BMC Medicine

Fig. 1

From: The VENUSS prognostic model to predict disease recurrence following surgery for non-metastatic papillary renal cell carcinoma: development and evaluation using the ASSURE prospective clinical trial cohort

Fig. 1

Cumulative incidence of disease recurrence of 556 who underwent surgery for non-metastatic papillary renal cell carcinoma and according to the first site of recurrence. Twenty patients first recurred simultaneously in the abdomen and chest and are included in both curves. a Overall, the cumulative incidence rate of disease recurrence was 11.7% at 5 years. The most frequent site of recurrence was the abdomen. b Cumulative incidence curve of disease recurrence according to VENUSS score. c Cumulative incidence curve of disease recurrence according to VENUSS group

Back to article page